Abstract
Treatment of respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, depends primarily on inhaled medications. Because of the complexity of inhaled medication delivery, patients' mastery of inhalers presents a major challenge to these treatments. Further, the skill requirements vary across medication devices, including metered-dose inhalers (MDIs), breath-activated MDIs, soft-mist inhalers, drypowder inhalers (DPIs), and nebulizers, adding further potential confusion for both prescribers and patients. A large body of literature has documented the frequency of patient inhaler errors and the correlation of these with worsening outcomes 1 accounting for nearly $900 million in direct and indirect costs. 2 The manuscript by Cho-Reyes et al in this issue of the Journal of the COPD Foundation adds to this literature, combining a systematic review and meta-analysis. Ten previously published reports including 1360 patients revealed that

This publication has 10 references indexed in Scilit: